Camber Pharmaceuticals, one of the industry’s fastest growing generic pharmaceutical companies is pleased to announce the addition of six new products to its rapidly expanding product line.
Quinapril HCTZ Naproxen Levetiracetam
– 10/12.5mg/90ct – 250mg/100ct and 500ct – 250mg/ 120ct and 500ct – 1000mg/ 60ct
– 20/12.5mg/90ct – 375mg/ 100ct and 500ct – 500mg/120ct and 500ct
– 20/25mg/90ct – 500mg/ 100ct and 500ct – 750mg/120ct and 500ct
Quinapril Naproxen DR Alfuzosin
– 5mg/90ct – 375mg/100ct – 10mg/100ct
– 10mg/90ct – 500mg/100ct
– 20mg/90ct – 500mg/500ct
Camber Pharmaceuticals is a fully integrated international pharmaceutical company that maintains quality and integrity in all its products from API manufacturing to finished dosage. Camber’s parent company Hetero Drugs of Hyderabad, India employs over 300 scientists at 9 API facilities and has a global presence in over 100 countries.
- Camber Pharmaceuticals Launches Generic Pepcid®
- Camber Pharmaceuticals Launches Generic Wellbutrin SR®
- Camber Pharmaceuticals Launches Generic Inspra®
- Camber Pharmaceuticals Launches Generic Prezista®
- Camber Pharmaceuticals Launches Generic Neurontin Caps®
- Camber Pharmaceuticals Launches Generic Zyprexa®